152 related articles for article (PubMed ID: 27062033)
21. Loss of H2Bub1 Expression is Linked to Poor Prognosis in Nodal Negative Colorectal Cancers.
Melling N; Grimm N; Simon R; Stahl P; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
Pathol Oncol Res; 2016 Jan; 22(1):95-102. PubMed ID: 26347467
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomas.
Yoshioka Y; Togashi Y; Chikugo T; Kogita A; Taguri M; Terashima M; Mizukami T; Hayashi H; Sakai K; de Velasco MA; Tomida S; Fujita Y; Tokoro T; Ito A; Okuno K; Nishio K
Cancer; 2015 Dec; 121(24):4359-68. PubMed ID: 26488212
[TBL] [Abstract][Full Text] [Related]
23. Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia.
Drapkin R; Crum CP; Hecht JL
Hum Pathol; 2004 Aug; 35(8):1014-21. PubMed ID: 15297969
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
25. Nuclear aldehyde dehydrogenase 1A1 (ALDH1A1) expression is a favorable prognostic indicator in colorectal carcinoma.
Wang L; Lin D; Fu Y; Lai M
Pathol Res Pract; 2016 Sep; 212(9):791-9. PubMed ID: 27461829
[TBL] [Abstract][Full Text] [Related]
26. Mesothelin expression in pancreatic mucinous cysts.
Frank R; Li S; Ahmad NA; Sepulveda AR; Jhala NC
Am J Clin Pathol; 2014 Sep; 142(3):313-9. PubMed ID: 25125620
[TBL] [Abstract][Full Text] [Related]
27. Implication of the Galectin-3 in colorectal cancer development (about 325 Tunisian patients).
Arfaoui-Toumi A; Kria-Ben Mahmoud L; Ben Hmida M; Khalfallah MT; Regaya-Mzabi S; Bouraoui S
Bull Cancer; 2010 Feb; 97(2):E1-8. PubMed ID: 20080461
[TBL] [Abstract][Full Text] [Related]
28. Mesothelin expression has prognostic value in stage ΙΙ/ΙΙΙ colorectal cancer.
Shiraishi T; Shinto E; Mochizuki S; Tsuda H; Kajiwara Y; Okamoto K; Einama T; Hase K; Ueno H
Virchows Arch; 2019 Mar; 474(3):297-307. PubMed ID: 30603773
[TBL] [Abstract][Full Text] [Related]
29. Calretinin expression as a reliable prognostic marker in different molecular subtypes of breast carcinoma.
Farrag MS; El-Karef AA; Amin MM; Helal NM; Ali OF; Farrag NS
Indian J Pathol Microbiol; 2017; 60(1):8-14. PubMed ID: 28195084
[TBL] [Abstract][Full Text] [Related]
30. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y
J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938
[TBL] [Abstract][Full Text] [Related]
31. Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer.
Einama T; Homma S; Kamachi H; Kawamata F; Takahashi K; Takahashi N; Taniguchi M; Kamiyama T; Furukawa H; Matsuno Y; Tanaka S; Nishihara H; Taketomi A; Todo S
Br J Cancer; 2012 Jun; 107(1):137-42. PubMed ID: 22644300
[TBL] [Abstract][Full Text] [Related]
32. Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer.
Zlatian OM; Comănescu MV; Roşu AF; Roşu L; Cruce M; Găman AE; Călina CD; Sfredel V
Rom J Morphol Embryol; 2015; 56(1):175-81. PubMed ID: 25826503
[TBL] [Abstract][Full Text] [Related]
33. [Epidemiological study, pathologic evaluation and prognostic factors of colorectal mucinous vs non-mucinous adenocarcinoma (a series of 196 patients)].
Arfaoui Toumi A; Kriaa Ben Mahmoud L; Khiari M; Lahmer A; Gharbi L; Dhraïef M; Khalfallah T; Regaya Mzabi S; Bouraoui S
Tunis Med; 2010 Jan; 88(1):12-7. PubMed ID: 20415207
[TBL] [Abstract][Full Text] [Related]
34. Two subtypes of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features.
Leopoldo S; Lorena B; Cinzia A; Gabriella DC; Angela Luciana B; Renato C; Antonio M; Carlo S; Cristina P; Stefano C; Maurizio T; Luigi R; Cesare B
Ann Surg Oncol; 2008 May; 15(5):1429-39. PubMed ID: 18301950
[TBL] [Abstract][Full Text] [Related]
35. Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis.
Perez RO; Bresciani BH; Bresciani C; Proscurshim I; Kiss D; Gama-Rodrigues J; Pereira DD; Rawet V; Cecconnello I; Habr-Gama A
Int J Colorectal Dis; 2008 Aug; 23(8):757-65. PubMed ID: 18458918
[TBL] [Abstract][Full Text] [Related]
36. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological characteristics of mucinous and non-mucinous adenocarcinoma in the colon and rectum in Rajavithi Hospital, Thailand.
Jivapaisarnpong P; Boonthongtho K
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S41-5. PubMed ID: 21717877
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
[TBL] [Abstract][Full Text] [Related]
39. Prognostic implication of mucinous histology in resected colorectal cancer liver metastases.
Lupinacci RM; Mello ES; Coelho FF; Kruger JA; Perini MV; Pinheiro RS; Fonseca GM; Cecconello I; Herman P
Surgery; 2014 Jun; 155(6):1062-8. PubMed ID: 24856126
[TBL] [Abstract][Full Text] [Related]
40. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer.
Mekenkamp LJ; Heesterbeek KJ; Koopman M; Tol J; Teerenstra S; Venderbosch S; Punt CJ; Nagtegaal ID
Eur J Cancer; 2012 Mar; 48(4):501-9. PubMed ID: 22226571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
